Projects
Close Projects
Open Projects
Technology Platform
Pipeline
Stem Cell Therapy
Cancer Therapy
Indications
Publications
Investors
Close Investors
Open Investors
Share Information
Financial Reports
Financial Calendar
Analyses
Share issues
Management & Board
Corporate Governance
General Meetings
IR Contact / Certified Adviser
Media
Close Media
Open Media
Xintelling – Newsletter
Press Releases
Events
Xintela in the news
Videos
About Xintela
Close About Xintela
Open About Xintela
About the company
History
Business Development
Contact
SV
SV
SV
News and Media
Here you can read more about Xintela’s news.
Xintelling - Newsletter
30 October 2025
New issue of Xintelling No. 2 2025
12 May 2025
New issue of Xintelling No. 6 2025
27 December 2024
New issue of Xintelling No. 5 2024
7 October 2024
New issue of Xintelling, No. 4 2024
1 July 2024
New issue of Xintelling, No. 3 2024
5 April 2024
New issue of Xintelling, No. 2 2024
Show more
Inga fler inlägg att visa
Press Releases
Alla
News
Regulatory
MAR
February 27, 2026
Xintela AB Year-end Report 2025
February 20, 2026
New issue of Xintelling No. 1 2026
February 13, 2026
Xintela completes clinical study with XSTEM in difficult-to-heal leg ulcers
November 4, 2025
Xintela AB Interim Report January – September 2025
October 30, 2025
New issue of Xintelling No. 2 2025
October 30, 2025
Last patient dosed in Xintela’s clinical study on difficult-to-heal leg ulcers
Show more
Event
2026-05-20
– 2026-05-22
22nd ESSKA Congress, Prague (Czech Republic)
2026-05-04
– 2026-05-06
27th EFORT Annual Congress, Málaga (Spain)
Xintela in the news
Targinta in BioStock
22/01/2024
BioStock: Targinta’s CEO, “Strong interest in ADCs in 2023”
Read more
Xintela in DIs #InvestTalks
01/06/2023
DIs #InvestTalks – Xintela develops new generation stem cell products
Read more
Xintela in BioStock
30/05/2023
BioStock: Xintela highlights the unique properties of XSTEM
Read more
Xintela in BioStock
02/05/2023
BioStock: Xintela initiates last dose level in knee osteoarthritis study
Read more
Video
Projects
Technology Platform
Pipeline
Stem cell therapy
Cancer Therapy
Indications
Publications
Investors
Share Information
Financial Reports
Financial Calendar
Analyses
Share issues
Management & Board
Corporate Governance
General Meetings
IR-contact / Certified Adviser
Media
Xintelling – Newsletter
Press Releases
Events
Xintela in the news
Videos
About Xintela
About the company
History
Business Development
Contact
Research & Development
Integrin α10β1
Pipeline
TARG9
TARG10
Cancer Indications
About Targinta
Management & Board
Business Development
Invest
Contact